151 related articles for article (PubMed ID: 36184124)
1. Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.
Kambayashi R; Goto A; Izumi-Nakaseko H; Oikawa I; Ikeda N; Matsuda K; Takei Y; Matsumoto A; Kumagai Y; Sugiyama A
J Pharmacol Sci; 2022 Nov; 150(3):191-199. PubMed ID: 36184124
[TBL] [Abstract][Full Text] [Related]
2. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
Hossain M; Zhou M; Tiffany C; Dumont E; Darpo B
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.
Morganroth J; Wang Y; Thorn M; Kumagai Y; Harris S; Stockbridge N; Kleiman R; Shah R
Br J Clin Pharmacol; 2015 Sep; 80(3):446-59. PubMed ID: 26011050
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers.
Wu J; Cao G; Wu H; Chen Y; Guo B; Wu X; Yu J; Ni K; Qian J; Wang L; Wu J; Wang Y; Yuan H; Zhang J; Xi Y
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229495
[TBL] [Abstract][Full Text] [Related]
6. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
[TBL] [Abstract][Full Text] [Related]
7. Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy Filipino subjects: Exposure-response modeling using ECG data of thorough QT/QTc study.
Matsukura S; Nakamura Y; Hoshiai K; Hayashi T; Koga T; Goto A; Chiba K; Lubna NJ; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Ando K; Naito AT; Sugiyama A
J Pharmacol Sci; 2018 Apr; 136(4):234-241. PubMed ID: 29627227
[TBL] [Abstract][Full Text] [Related]
8. Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study.
Shah RR; Maison-Blanche P; Duvauchelle T; Robert P; Denis E
Eur J Clin Pharmacol; 2015 Dec; 71(12):1451-9. PubMed ID: 26423621
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.
Taubel J; Naseem A; Harada T; Wang D; Arezina R; Lorch U; Camm AJ
Br J Clin Pharmacol; 2010 Apr; 69(4):391-400. PubMed ID: 20406223
[TBL] [Abstract][Full Text] [Related]
10. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
Stier B; Fossler M; Liu F; Caltabiano S
Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
[TBL] [Abstract][Full Text] [Related]
11. Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.
Täubel J; Ferber G; Fox G; Fernandes S; Lorch U; Camm AJ
Br J Clin Pharmacol; 2017 Feb; 83(2):339-348. PubMed ID: 27618796
[TBL] [Abstract][Full Text] [Related]
12. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
[TBL] [Abstract][Full Text] [Related]
13. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.
Taubel J; Ferber G; Lorch U; Batchvarov V; Savelieva I; Camm AJ
Br J Clin Pharmacol; 2014 Jan; 77(1):170-9. PubMed ID: 23713767
[TBL] [Abstract][Full Text] [Related]
14. Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.
Panicker GK; Karnad DR; Kadam P; Badilini F; Damle A; Kothari S
Br J Pharmacol; 2016 Apr; 173(8):1373-80. PubMed ID: 26784016
[TBL] [Abstract][Full Text] [Related]
15. Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjects.
Funck-Brentano C; Felices M; Le Fur N; Dubourdieu C; Desché P; Vanhoutte F; Voiriot P
Br J Clin Pharmacol; 2020 Nov; 86(11):2174-2181. PubMed ID: 32302009
[TBL] [Abstract][Full Text] [Related]
16. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
[TBL] [Abstract][Full Text] [Related]
17. Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.
Newman LM; Kankam M; Nakamura A; Conrad T; Mueller J; O'Donnell J; Osborn BL; Gu K; Saviolakis GA
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0129221. PubMed ID: 34606332
[TBL] [Abstract][Full Text] [Related]
18. Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist.
Shah RR; Maison-Blanche P; Robert P; Denis E; Duvauchelle T
Eur J Clin Pharmacol; 2016 May; 72(5):533-43. PubMed ID: 26879827
[TBL] [Abstract][Full Text] [Related]
19. Verinurad does not prolong QTc interval: a thorough QT study using concentration-QTc modelling.
Parkinson J; Dota C; Källgren C; Gottfridsson C; Bjursell M; Perl S; Kӧrnicke T; Rekić D; Johansson S
Br J Clin Pharmacol; 2023 Jun; 89(6):1747-1755. PubMed ID: 36504291
[TBL] [Abstract][Full Text] [Related]
20. Assay sensitivity in "Hybrid thorough QT/QTc (TQT)" study.
Huang DP; Chen J; Dang Q; Tsong Y
J Biopharm Stat; 2019; 29(2):378-384. PubMed ID: 30346877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]